glp-1 and diabetes GLP-1-based therapies for type 2 diabetes: from single, dual triple agonists to endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome Non-insulin injectable antidiabetic drugs -

Doctors have a real clear big picture of what the patients true blood pressure readings are, and that's where it goes into better treatment plans as it relates to physical activity, diet, and so forth

research found a 20 percent reduction in cardiovascular events (stroke and heart attacks) over a three-year period in a high-risk group

The first patients of these medications were people with Type 2 diabetes, as their main purpose is to assist in the management of blood sugar (glucose) levels

These early symptoms reflect the drug working as intendedslowing gastric emptying and activating satiety pathways in your brain